[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

Global Axitinib Sales Market Report 2017

February 2017 | 114 pages | ID: GE3403A69D3EN
QYResearch

US$ 4,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Notes:

Sales, means the sales volume of Axitinib

Revenue, means the sales value of Axitinib

This report studies sales (consumption) of Axitinib in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering
  • Pfizer
  • Allergan
  • Alnylam Pharmaceuticals
  • Amgen
  • Angstrom Pharmaceuticals
  • Acceleron Pharma
  • Biocon
  • Bionomics
  • CASI Pharmaceuticals
  • Celgene Corporation
  • Enzon Pharmaceuticals
  • Five Prime Therapeutics
  • Fujifilm Kyowa Kirin Biologics
  • Genentech
Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Axitinib in these regions, from 2011 to 2021 (forecast), like
  • United States
  • China
  • Europe
  • Japan
  • Southeast Asia
  • India
Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into
  • Type I
  • Type II
Split by applications, this report focuses on sales, market share and growth rate of Axitinib in each application, can be divided into
  • Application 1
  • Application 2
Global Axitinib Sales Market Report 2017

1 AXITINIB OVERVIEW

1.1 Product Overview and Scope of Axitinib
1.2 Classification of Axitinib
  1.2.1 Type I
  1.2.2 Type II
1.3 Application of Axitinib
  1.3.1 Application
  1.3.2 Application
1.4 Axitinib Market by Regions
  1.4.1 United States Status and Prospect (2012-2022)
  1.4.2 China Status and Prospect (2012-2022)
  1.4.3 Europe Status and Prospect (2012-2022)
  1.4.4 Japan Status and Prospect (2012-2022)
  1.4.5 Southeast Asia Status and Prospect (2012-2022)
  1.4.6 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value and Volume) of Axitinib (2012-2022)
  1.5.1 Global Axitinib Sales and Growth Rate (2012-2022)
  1.5.2 Global Axitinib Revenue and Growth Rate (2012-2022)

2 GLOBAL AXITINIB COMPETITION BY MANUFACTURERS, TYPE AND APPLICATION

2.1 Global Axitinib Market Competition by Manufacturers
  2.1.1 Global Axitinib Sales and Market Share of Key Manufacturers (2012-2017)
  2.1.2 Global Axitinib Revenue and Share by Manufacturers (2012-2017)
2.2 Global Axitinib (Volume and Value) by Type
  2.2.1 Global Axitinib Sales and Market Share by Type (2012-2017)
  2.2.2 Global Axitinib Revenue and Market Share by Type (2012-2017)
2.3 Global Axitinib (Volume and Value) by Regions
  2.3.1 Global Axitinib Sales and Market Share by Regions (2012-2017)
  2.3.2 Global Axitinib Revenue and Market Share by Regions (2012-2017)
2.4 Global Axitinib (Volume) by Application

3 UNITED STATES AXITINIB (VOLUME, VALUE AND SALES PRICE)

3.1 United States Axitinib Sales and Value (2012-2017)
  3.1.1 United States Axitinib Sales and Growth Rate (2012-2017)
  3.1.2 United States Axitinib Revenue and Growth Rate (2012-2017)
  3.1.3 United States Axitinib Sales Price Trend (2012-2017)
3.2 United States Axitinib Sales and Market Share by Manufacturers
3.3 United States Axitinib Sales and Market Share by Type
3.4 United States Axitinib Sales and Market Share by Application

4 CHINA AXITINIB (VOLUME, VALUE AND SALES PRICE)

4.1 China Axitinib Sales and Value (2012-2017)
  4.1.1 China Axitinib Sales and Growth Rate (2012-2017)
  4.1.2 China Axitinib Revenue and Growth Rate (2012-2017)
  4.1.3 China Axitinib Sales Price Trend (2012-2017)
4.2 China Axitinib Sales and Market Share by Manufacturers
4.3 China Axitinib Sales and Market Share by Type
4.4 China Axitinib Sales and Market Share by Application

5 EUROPE AXITINIB (VOLUME, VALUE AND SALES PRICE)

5.1 Europe Axitinib Sales and Value (2012-2017)
  5.1.1 Europe Axitinib Sales and Growth Rate (2012-2017)
  5.1.2 Europe Axitinib Revenue and Growth Rate (2012-2017)
  5.1.3 Europe Axitinib Sales Price Trend (2012-2017)
5.2 Europe Axitinib Sales and Market Share by Manufacturers
5.3 Europe Axitinib Sales and Market Share by Type
5.4 Europe Axitinib Sales and Market Share by Application

6 JAPAN AXITINIB (VOLUME, VALUE AND SALES PRICE)

6.1 Japan Axitinib Sales and Value (2012-2017)
  6.1.1 Japan Axitinib Sales and Growth Rate (2012-2017)
  6.1.2 Japan Axitinib Revenue and Growth Rate (2012-2017)
  6.1.3 Japan Axitinib Sales Price Trend (2012-2017)
6.2 Japan Axitinib Sales and Market Share by Manufacturers
6.3 Japan Axitinib Sales and Market Share by Type
6.4 Japan Axitinib Sales and Market Share by Application

7 SOUTHEAST ASIA AXITINIB (VOLUME, VALUE AND SALES PRICE)

7.1 Southeast Asia Axitinib Sales and Value (2012-2017)
  7.1.1 Southeast Asia Axitinib Sales and Growth Rate (2012-2017)
  7.1.2 Southeast Asia Axitinib Revenue and Growth Rate (2012-2017)
  7.1.3 Southeast Asia Axitinib Sales Price Trend (2012-2017)
7.2 Southeast Asia Axitinib Sales and Market Share by Manufacturers
7.3 Southeast Asia Axitinib Sales and Market Share by Type
7.4 Southeast Asia Axitinib Sales and Market Share by Application

8 INDIA AXITINIB (VOLUME, VALUE AND SALES PRICE)

8.1 India Axitinib Sales and Value (2012-2017)
  8.1.1 India Axitinib Sales and Growth Rate (2012-2017)
  8.1.2 India Axitinib Revenue and Growth Rate (2012-2017)
  8.1.3 India Axitinib Sales Price Trend (2012-2017)
8.2 India Axitinib Sales and Market Share by Manufacturers
8.3 India Axitinib Sales and Market Share by Type
8.4 India Axitinib Sales and Market Share by Application

9 GLOBAL AXITINIB MANUFACTURERS ANALYSIS

9.1 Pfizer
  9.1.1 Company Basic Information, Manufacturing Base and Competitors
  9.1.2 Axitinib Product Type, Application and Specification
    9.1.2.1 Product A
    9.1.2.2 Product B
  9.1.3 Pfizer Axitinib Sales, Revenue, Price and Gross Margin (2012-2017)
  9.1.4 Main Business/Business Overview
9.2 Allergan
  9.2.1 Company Basic Information, Manufacturing Base and Competitors
  9.2.2 Axitinib Product Type, Application and Specification
    9.2.2.1 Product A
    9.2.2.2 Product B
  9.2.3 Allergan Axitinib Sales, Revenue, Price and Gross Margin (2012-2017)
  9.2.4 Main Business/Business Overview
9.3 Alnylam Pharmaceuticals
  9.3.1 Company Basic Information, Manufacturing Base and Competitors
  9.3.2 Axitinib Product Type, Application and Specification
    9.3.2.1 Product A
    9.3.2.2 Product B
  9.3.3 Alnylam Pharmaceuticals Axitinib Sales, Revenue, Price and Gross Margin (2012-2017)
  9.3.4 Main Business/Business Overview
9.4 Amgen
  9.4.1 Company Basic Information, Manufacturing Base and Competitors
  9.4.2 Axitinib Product Type, Application and Specification
    9.4.2.1 Product A
    9.4.2.2 Product B
  9.4.3 Amgen Axitinib Sales, Revenue, Price and Gross Margin (2012-2017)
  9.4.4 Main Business/Business Overview
9.5 Angstrom Pharmaceuticals
  9.5.1 Company Basic Information, Manufacturing Base and Competitors
  9.5.2 Axitinib Product Type, Application and Specification
    9.5.2.1 Product A
    9.5.2.2 Product B
  9.5.3 Angstrom Pharmaceuticals Axitinib Sales, Revenue, Price and Gross Margin (2012-2017)
  9.5.4 Main Business/Business Overview
9.6 Acceleron Pharma
  9.6.1 Company Basic Information, Manufacturing Base and Competitors
  9.6.2 Axitinib Product Type, Application and Specification
    9.6.2.1 Product A
    9.6.2.2 Product B
  9.6.3 Acceleron Pharma Axitinib Sales, Revenue, Price and Gross Margin (2012-2017)
  9.6.4 Main Business/Business Overview
9.7 Biocon
  9.7.1 Company Basic Information, Manufacturing Base and Competitors
  9.7.2 Axitinib Product Type, Application and Specification
    9.7.2.1 Product A
    9.7.2.2 Product B
  9.7.3 Biocon Axitinib Sales, Revenue, Price and Gross Margin (2012-2017)
  9.7.4 Main Business/Business Overview
9.8 Bionomics
  9.8.1 Company Basic Information, Manufacturing Base and Competitors
  9.8.2 Axitinib Product Type, Application and Specification
    9.8.2.1 Product A
    9.8.2.2 Product B
  9.8.3 Bionomics Axitinib Sales, Revenue, Price and Gross Margin (2012-2017)
  9.8.4 Main Business/Business Overview
9.9 CASI Pharmaceuticals
  9.9.1 Company Basic Information, Manufacturing Base and Competitors
  9.9.2 Axitinib Product Type, Application and Specification
    9.9.2.1 Product A
    9.9.2.2 Product B
  9.9.3 CASI Pharmaceuticals Axitinib Sales, Revenue, Price and Gross Margin (2012-2017)
  9.9.4 Main Business/Business Overview
9.10 Celgene Corporation
  9.10.1 Company Basic Information, Manufacturing Base and Competitors
  9.10.2 Axitinib Product Type, Application and Specification
    9.10.2.1 Product A
    9.10.2.2 Product B
  9.10.3 Celgene Corporation Axitinib Sales, Revenue, Price and Gross Margin (2012-2017)
  9.10.4 Main Business/Business Overview
9.11 Enzon Pharmaceuticals
9.12 Five Prime Therapeutics
9.13 Fujifilm Kyowa Kirin Biologics
9.14 Genentech

10 AXITINIB MAUFACTURING COST ANALYSIS

10.1 Axitinib Key Raw Materials Analysis
  10.1.1 Key Raw Materials
  10.1.2 Price Trend of Key Raw Materials
  10.1.3 Key Suppliers of Raw Materials
  10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
  10.2.1 Raw Materials
  10.2.2 Labor Cost
  10.2.3 Manufacturing Process Analysis of Axitinib
10.3 Manufacturing Process Analysis of Axitinib

11 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

11.1 Axitinib Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Axitinib Major Manufacturers in 2015
11.4 Downstream Buyers

12 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

12.1 Marketing Channel
  12.1.1 Direct Marketing
  12.1.2 Indirect Marketing
  12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
  12.2.1 Pricing Strategy
  12.2.2 Brand Strategy
  12.2.3 Target Client
12.3 Distributors/Traders List

13 MARKET EFFECT FACTORS ANALYSIS

13.1 Technology Progress/Risk
  13.1.1 Substitutes Threat
  13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 GLOBAL AXITINIB MARKET FORECAST (2017-2022)

14.1 Global Axitinib Sales, Revenue and Price Forecast (2017-2022)
  14.1.1 Global Axitinib Sales and Growth Rate Forecast (2017-2022)
  14.1.2 Global Axitinib Revenue and Growth Rate Forecast (2017-2022)
  14.1.3 Global Axitinib Price and Trend Forecast (2017-2022)
14.2 Global Axitinib Sales, Revenue and Growth Rate Forecast by Regions (2017-2022)
  14.2.1 United States Axitinib Sales, Revenue and Growth Rate Forecast (2017-2022)
  14.2.2 China Axitinib Sales, Revenue and Growth Rate Forecast (2017-2022)
  14.2.3 Europe Axitinib Sales, Revenue and Growth Rate Forecast (2017-2022)
  14.2.4 Japan Axitinib Sales, Revenue and Growth Rate Forecast (2017-2022)
  14.2.5 Southeast Asia Axitinib Sales, Revenue and Growth Rate Forecast (2017-2022)
  14.2.6 India Axitinib Sales, Revenue and Growth Rate Forecast (2017-2022)
14.3 Global Axitinib Sales, Revenue and Price Forecast by Type (2017-2022)
14.4 Global Axitinib Sales Forecast by Application (2017-2022)

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Picture of Axitinib
Table Classification of Axitinib
Figure Global Sales Market Share of Axitinib by Type in 2015
Figure Type I Picture
Figure Type II Picture
Table Applications of Axitinib
Figure Global Sales Market Share of Axitinib by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure United States Axitinib Revenue and Growth Rate (2012-2022)
Figure China Axitinib Revenue and Growth Rate (2012-2022)
Figure Europe Axitinib Revenue and Growth Rate (2012-2022)
Figure Japan Axitinib Revenue and Growth Rate (2012-2022)
Figure Southeast Asia Axitinib Revenue and Growth Rate (2012-2022)
Figure India Axitinib Revenue and Growth Rate (2012-2022)
Figure Global Axitinib Sales and Growth Rate (2012-2022)
Figure Global Axitinib Revenue and Growth Rate (2012-2022)
Table Global Axitinib Sales of Key Manufacturers (2012-2017)
Table Global Axitinib Sales Share by Manufacturers (2012-2017)
Figure 2015 Axitinib Sales Share by Manufacturers
Figure 2016 Axitinib Sales Share by Manufacturers
Table Global Axitinib Revenue by Manufacturers (2012-2017)
Table Global Axitinib Revenue Share by Manufacturers (2012-2017)
Table 2015 Global Axitinib Revenue Share by Manufacturers
Table 2016 Global Axitinib Revenue Share by Manufacturers
Table Global Axitinib Sales and Market Share by Type (2012-2017)
Table Global Axitinib Sales Share by Type (2012-2017)
Figure Sales Market Share of Axitinib by Type (2012-2017)
Figure Global Axitinib Sales Growth Rate by Type (2012-2017)
Table Global Axitinib Revenue and Market Share by Type (2012-2017)
Table Global Axitinib Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Axitinib by Type (2012-2017)
Figure Global Axitinib Revenue Growth Rate by Type (2012-2017)
Table Global Axitinib Sales and Market Share by Regions (2012-2017)
Table Global Axitinib Sales Share by Regions (2012-2017)
Figure Sales Market Share of Axitinib by Regions (2012-2017)
Figure Global Axitinib Sales Growth Rate by Regions (2012-2017)
Table Global Axitinib Revenue and Market Share by Regions (2012-2017)
Table Global Axitinib Revenue Share by Regions (2012-2017)
Figure Revenue Market Share of Axitinib by Regions (2012-2017)
Figure Global Axitinib Revenue Growth Rate by Regions (2012-2017)
Table Global Axitinib Sales and Market Share by Application (2012-2017)
Table Global Axitinib Sales Share by Application (2012-2017)
Figure Sales Market Share of Axitinib by Application (2012-2017)
Figure Global Axitinib Sales Growth Rate by Application (2012-2017)
Figure United States Axitinib Sales and Growth Rate (2012-2017)
Figure United States Axitinib Revenue and Growth Rate (2012-2017)
Figure United States Axitinib Sales Price Trend (2012-2017)
Table United States Axitinib Sales by Manufacturers (2012-2017)
Table United States Axitinib Market Share by Manufacturers (2012-2017)
Table United States Axitinib Sales by Type (2012-2017)
Table United States Axitinib Market Share by Type (2012-2017)
Table United States Axitinib Sales by Application (2012-2017)
Table United States Axitinib Market Share by Application (2012-2017)
Figure China Axitinib Sales and Growth Rate (2012-2017)
Figure China Axitinib Revenue and Growth Rate (2012-2017)
Figure China Axitinib Sales Price Trend (2012-2017)
Table China Axitinib Sales by Manufacturers (2012-2017)
Table China Axitinib Market Share by Manufacturers (2012-2017)
Table China Axitinib Sales by Type (2012-2017)
Table China Axitinib Market Share by Type (2012-2017)
Table China Axitinib Sales by Application (2012-2017)
Table China Axitinib Market Share by Application (2012-2017)
Figure Europe Axitinib Sales and Growth Rate (2012-2017)
Figure Europe Axitinib Revenue and Growth Rate (2012-2017)
Figure Europe Axitinib Sales Price Trend (2012-2017)
Table Europe Axitinib Sales by Manufacturers (2012-2017)
Table Europe Axitinib Market Share by Manufacturers (2012-2017)
Table Europe Axitinib Sales by Type (2012-2017)
Table Europe Axitinib Market Share by Type (2012-2017)
Table Europe Axitinib Sales by Application (2012-2017)
Table Europe Axitinib Market Share by Application (2012-2017)
Figure Japan Axitinib Sales and Growth Rate (2012-2017)
Figure Japan Axitinib Revenue and Growth Rate (2012-2017)
Figure Japan Axitinib Sales Price Trend (2012-2017)
Table Japan Axitinib Sales by Manufacturers (2012-2017)
Table Japan Axitinib Market Share by Manufacturers (2012-2017)
Table Japan Axitinib Sales by Type (2012-2017)
Table Japan Axitinib Market Share by Type (2012-2017)
Table Japan Axitinib Sales by Application (2012-2017)
Table Japan Axitinib Market Share by Application (2012-2017)
Figure Southeast Asia Axitinib Sales and Growth Rate (2012-2017)
Figure Southeast Asia Axitinib Revenue and Growth Rate (2012-2017)
Figure Southeast Asia Axitinib Sales Price Trend (2012-2017)
Table Southeast Asia Axitinib Sales by Manufacturers (2012-2017)
Table Southeast Asia Axitinib Market Share by Manufacturers (2012-2017)
Table Southeast Asia Axitinib Sales by Type (2012-2017)
Table Southeast Asia Axitinib Market Share by Type (2012-2017)
Table Southeast Asia Axitinib Sales by Application (2012-2017)
Table Southeast Asia Axitinib Market Share by Application (2012-2017)
Figure India Axitinib Sales and Growth Rate (2012-2017)
Figure India Axitinib Revenue and Growth Rate (2012-2017)
Figure India Axitinib Sales Price Trend (2012-2017)
Table India Axitinib Sales by Manufacturers (2012-2017)
Table India Axitinib Market Share by Manufacturers (2012-2017)
Table India Axitinib Sales by Type (2012-2017)
Table India Axitinib Market Share by Type (2012-2017)
Table India Axitinib Sales by Application (2012-2017)
Table India Axitinib Market Share by Application (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Axitinib Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Pfizer Axitinib Global Market Share (2012-2017)
Table Allergan Basic Information List
Table Allergan Axitinib Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Allergan Axitinib Global Market Share (2012-2017)
Table Alnylam Pharmaceuticals Basic Information List
Table Alnylam Pharmaceuticals Axitinib Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Alnylam Pharmaceuticals Axitinib Global Market Share (2012-2017)
Table Amgen Basic Information List
Table Amgen Axitinib Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Amgen Axitinib Global Market Share (2012-2017)
Table Angstrom Pharmaceuticals Basic Information List
Table Angstrom Pharmaceuticals Axitinib Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Angstrom Pharmaceuticals Axitinib Global Market Share (2012-2017)
Table Acceleron Pharma Basic Information List
Table Acceleron Pharma Axitinib Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Acceleron Pharma Axitinib Global Market Share (2012-2017)
Table Biocon Basic Information List
Table Biocon Axitinib Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Biocon Axitinib Global Market Share (2012-2017)
Table Bionomics Basic Information List
Table Bionomics Axitinib Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Bionomics Axitinib Global Market Share (2012-2017)
Table CASI Pharmaceuticals Basic Information List
Table CASI Pharmaceuticals Axitinib Sales, Revenue, Price and Gross Margin (2012-2017)
Figure CASI Pharmaceuticals Axitinib Global Market Share (2012-2017)
Table Celgene Corporation Basic Information List
Table Celgene Corporation Axitinib Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Celgene Corporation Axitinib Global Market Share (2012-2017)
Table Enzon Pharmaceuticals Basic Information List
Table Five Prime Therapeutics Basic Information List
Table Fujifilm Kyowa Kirin Biologics Basic Information List
Table Genentech Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Axitinib
Figure Manufacturing Process Analysis of Axitinib
Figure Axitinib Industrial Chain Analysis
Table Raw Materials Sources of Axitinib Major Manufacturers in 2015
Table Major Buyers of Axitinib
Table Distributors/Traders List
Figure Global Axitinib Sales and Growth Rate Forecast (2017-2022)
Figure Global Axitinib Revenue and Growth Rate Forecast (2017-2022)
Table Global Axitinib Sales Forecast by Regions (2017-2022)
Table Global Axitinib Sales Forecast by Type (2017-2022)
Table Global Axitinib Sales Forecast by Application (2017-2022)

More Publications

Need Help?

Ask a Question

Market Reports

All Categories